Titan America SA Just Missed Earnings - But Analysts Have Updated Their Models

Last week, you might have seen that Titan America SA (NYSE:TTAM) released its quarterly result to the market. The early response was not positive, with shares down 6.3% to US$15.91 in the past week. Statutory earnings per share of US$0.23 unfortunately missed expectations by 20%, although it was encouraging to see revenues of US$471m exceed expectations by 5.9%. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. So we gathered the latest post-earnings forecasts to see what estimates suggest is in store for next year.

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

Taking into account the latest results, the current consensus from Titan America's seven analysts is for revenues of US$1.78b in 2026. This would reflect a satisfactory 3.8% increase on its revenue over the past 12 months. Statutory earnings per share are predicted to climb 12% to US$1.08. Yet prior to the latest earnings, the analysts had been anticipated revenues of US$1.74b and earnings per share (EPS) of US$1.08 in 2026. So it looks like there's been no major change in sentiment following the latest results, although the analysts have made a slight bump in to revenue forecasts.

View our latest analysis for Titan America

Even though revenue forecasts increased, there was no change to the consensus price target of US$18.64, suggesting the analysts are focused on earnings as the driver of value creation. There's another way to think about price targets though, and that's to look at the range of price targets put forward by analysts, because a wide range of estimates could suggest a diverse view on possible outcomes for the business. Currently, the most bullish analyst values Titan America at US$22.00 per share, while the most bearish prices it at US$15.00. As you can see, analysts are not all in agreement on the stock's future, but the range of estimates is still reasonably narrow, which could suggest that the outcome is not totally unpredictable.

Of course, another way to look at these forecasts is to place them into context against the industry itself. It's clear from the latest estimates that Titan America's rate of growth is expected to accelerate meaningfully, with the forecast 7.8% annualised revenue growth to the end of 2026 noticeably faster than its historical growth of 5.5% over the past year. Compare this with other companies in the same industry, which are forecast to grow their revenue 6.1% annually. It seems obvious that, while the growth outlook is brighter than the recent past, the analysts also expect Titan America to grow faster than the wider industry.

The Bottom Line

The most important thing to take away is that there's been no major change in sentiment, with the analysts reconfirming that the business is performing in line with their previous earnings per share estimates. Happily, they also upgraded their revenue estimates, and are forecasting them to grow faster than the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.

With that in mind, we wouldn't be too quick to come to a conclusion on Titan America. Long-term earnings power is much more important than next year's profits. We have estimates - from multiple Titan America analysts - going out to 2028, and you can see them free on our platform here.

Before you take the next step you should know about the 1 warning sign for Titan America that we have uncovered.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.